SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: g.w. barnard who wrote (552)1/15/1998 5:28:00 PM
From: tony di fatta  Read Replies (1) | Respond to of 998
 
is this today's news , i have not seen it . i have owned this stock for over a year and got burned with call options expiring worthless
due to the non approval of myotrophin. i hope we get some good news soon. tony



To: g.w. barnard who wrote (552)1/16/1998 11:53:00 AM
From: JMarcus  Read Replies (1) | Respond to of 998
 
The stock is down $0.50 today. A negative reaction to the Reuters condescending remark that "[d]espite those claims, and the positive testimonials of many patients with Lou Gehrig's Disease, Cephalon has had trouble getting the Food and Drug Administration to approve Myotrophin"?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News